FDA approves second IGF-1R-targeted antibody for thyroid eye disease [0.03%]
FDA批准第二种IGF-1R靶向抗体治疗甲状腺眼病
Asher Mullard
Asher Mullard
Asher Mullard
Asher Mullard
Alex Eccleston
Alex Eccleston
Growth in clinical research capability in China and impact on the pharmaceutical sector [0.03%]
中国临床研究能力的增长及其对医药行业的影响
Huimin Guo,Mengze Ruan,Kenneth Kaitin et al.
Huimin Guo et al.
M Teresa Villanueva
M Teresa Villanueva
Sarah Crunkhorn
Sarah Crunkhorn
Sarah Crunkhorn
Sarah Crunkhorn
Sarah Crunkhorn
Sarah Crunkhorn
Pulsatile FXR agonism [0.03%]
脉冲式FXR激动剂治疗
Sarah Crunkhorn
Sarah Crunkhorn